Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2627 Target Snapshot

Dihydrofolate reductase type 1 · SINGLE PROTEIN · Escherichia coli

131Compounds
6Assays
1Approved Drugs
58.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P00382. Use UniProt P00382 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P00382 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dihydrofolate reductase type 1 as ChEMBL target CHEMBL2627, mapped to UniProt P00382. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dihydrofolate reductase type 1
SINGLE PROTEIN · Escherichia coli
As of 2026-09-14
ChEMBL target ID
CHEMBL2627
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P00382
Dihydrofolate reductase type 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dihydrofolate reductase type 1 is the right protein anchor across sources, using UniProt P00382 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDihydrofolate reductase type 1
UniProt AccessionP00382
Component TypeProtein
Sequence Length157 aa

Dihydrofolate reductase type 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dihydrofolate reductase type 1, mapped to UniProt P00382. Sequence length is 157 aa.

Mapped IDP00382
Review nameDihydrofolate reductase type 1
OrganismEscherichia coli
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC5047.0
KI11.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL57377 8.72 IC50 1.9 Preclinical
CHEMBL418293 8.7 IC50 2.0 Preclinical
CHEMBL58455 8.7 IC50 2.0 Preclinical
CHEMBL57458 8.62 IC50 2.4 Preclinical
CHEMBL300371 8.59 IC50 2.6 Preclinical
CHEMBL300385 8.51 IC50 3.1 Preclinical
CHEMBL294678 8.47 IC50 3.4 Preclinical
CHEMBL59491 8.17 IC50 6.8 Preclinical
CHEMBL60647 8.15 IC50 7.0 Preclinical
CHEMBL57807 8.13 IC50 7.4 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
3
6.0
10
6.5
9
7.0
13
7.5
8
8.0
6
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

TRIMETHOPRIM
CHEMBL22
Approved 1973
Assay Landscape

Assay Landscape

6
Total Assays
47
Tested Compounds
1
Assay Types
Binding — 6 assays, 47 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 6 47 7.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine